Skip to content

NYXOAH

Active
Public limited companyfounded 200917 yrs activeRue Edouard Belin 12, 1435 Mont-Saint-Guibert, BelgiumKBO/BCE: BE 0817.149.675
Summary

The annual accounts of NYXOAH for fiscal year 2025 show a net loss of 81% of total assets and of 75% of the equity at the start of that year. The 2025 annual accounts show equity of €51.95M and a net result of €-90.91M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 46% of 117 sector peers (fiscal year 2025). The company has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.5% (very low).

Checked score

Score 2025
52 / 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0=
Solvency71▼-29
Growth68=
Track record100
Bankruptcy probability, 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €800k at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 1.82 against 6.43 in 2024; short-term debt: 26.5% and cash: 4.2% of total assets), but 53.6% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 32
Relative position
BE, all sectors
reference
Sector 32
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 17 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
46.4%
Return on assets
-81.2%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year €-90.91M
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
18 d early
2024
20 d early
2023
23 d early
2022
18 d early
2021
16 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema, statutory accounts

Turnover
€8.29M▲ 82.9%
2024 · €4.53M
2020: €69k 2021: €863k 2022: €3.10M 2023: €4.38M 2024: €4.53M
2020 → 2025
EBIT margin
-1064.1%▲ 379.2pp
2024 · -1443.3%
2020: -12980.2% 2021: -3224.8% 2022: -1051.6% 2023: -1064.3% 2024: -1443.3%
2020 → 2025
Net result
€-90.91M▼ 48.5%
2024 · €-61.21M
2018: €-8.90M 2019: €-6.67M 2020: €-11.13M 2021: €-27.02M 2022: €-29.63M 2023: €-44.77M 2024: €-61.21M
2018 → 2025
Working capital
€24.23M▼ 68.7%
2024 · €77.41M
2018: €15.29M 2019: €3.89M 2020: €86.72M 2021: €130.00M 2022: €87.65M 2023: €54.35M 2024: €77.41M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€863k-€3.10M▲ 259%€4.38M▲ 41.4%€4.53M▲ 3.5%€8.29M▲ 82.9%
Equity€164.07M-€134.70M▼ 17.9%€108.60M▼ 19.4%€120.84M▲ 11.3%€51.95M▼ 57.0%
Operating result€-27.83M-€-32.55M▼ 17.0%€-46.60M▼ 43.2%€-65.41M▼ 40.4%€-88.21M▼ 34.9%
Net result€-27.02M-€-29.63M▼ 9.6%€-44.77M▼ 51.1%€-61.21M▼ 36.7%€-90.91M▼ 48.5%
Result per fiscal year
Operating resultNet result
€-100.00M€-75.00M€-50.00M€-25.00M€0Operating result 2021: €-27.83M€-27.83MNet result 2021: €-27.02M€-27.02MOperating result 2022: €-32.55M€-32.55MNet result 2022: €-29.63M€-29.63MOperating result 2023: €-46.60M€-46.60MNet result 2023: €-44.77M€-44.77MOperating result 2024: €-65.41M€-65.41MNet result 2024: €-61.21M€-61.21MOperating result 2025: €-88.21M€-88.21MNet result 2025: €-90.91M€-90.91M20212022202320242025€-100M€-75M€-50M€-25M€0Operating result 2023: €-46.60M€-47MNet result 2023: €-44.77M€-45MOperating result 2024: €-65.41M€-65MNet result 2024: €-61.21M€-61MOperating result 2025: €-88.21M€-88MNet result 2025: €-90.91M€-91M202320242025
The operating result stays negative: a loss of €88.21M in 2025 against €65.41M in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €107.32M
Fixed assets €53.38M ▼ 0.7%
Current assets €53.94M ▼ 41.1%
Equity and liabilities €112.00M
Equity €51.95M ▼ 57.0%
Provisions €2.90M ▼ 31.1%
Debt €57.16M ▲ 110%
Debt's share of the balance-sheet total rises from 17.9% to 51.0%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€-81.99M
2024 · €-60.87M
Cash flow
€-84.69M
2024 · €-56.67M
Current ratio
1.82
2024 · 6.43
Quick ratio
1.66
2024 · 6.10
Debt to equity
1.10
2024 · 0.23
ROE
-175.0%
2024 · -50.7%
ROA
-81.2%
2024 · -40.2%
Interest coverage
-68.26
2024 · -113.07
Debt ≤ 1 year
€29.71M
2024 · €14.25M
Debt > 1 year
€26.38M
2024 · €11.81M
Income taxes
€-97k
2024 · €-78k
Staff costs
€7.01M
2024 · €8.46M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 90 lines
Balance sheet Code20242025
Assets
Total assets20/58€152.27M€112.00M
Formation expenses20€6.86M€4.68M
Fixed assets21/28€53.75M€53.38M
Intangible fixed assets21€49.52M€49.46M
Tangible fixed assets22/27€4.15M€3.79M
Plant, machinery and equipment23€769k€616k
Furniture and vehicles24€144k€104k
Other tangible fixed assets26€982k€3.04M
Assets under construction and advance payments27€2.26M€30k
Financial fixed assets28€78k€125k
Affiliated companies280/1€29k€29k=
Participating interests280€29k€29k=
Other financial fixed assets284/8€48k€96k
Amounts receivable and cash guarantees285/8€48k€96k
Current assets29/58€91.66M€53.94M
Amounts receivable after more than one year29€1.20M€1.31M
Other amounts receivable291€1.20M€1.31M
Stocks and contracts in progress3€4.72M€4.66M
Stocks30/36€4.72M€4.66M
Raw materials and consumables30/31€1.08M€1.32M
Work in progress32€2.55M€1.85M
Finished goods33€1.09M€1.49M
Amounts receivable within one year40/41€6.44M€4.09M
Trade receivables40€4.09M€2.59M
Other amounts receivable41€2.35M€1.51M
Current investments50/53€76.01M€38.41M
Other investments51/53€76.01M€38.41M
Cash at bank and in hand54/58€1.70M€4.71M
Deferred charges and accrued income490/1€1.60M€760k
Equity and liabilities
Total equity and liabilities10/49€152.27M€112.00M
Equity10/15€120.84M€51.95M
Contributions10/11€339.01M€361.03M
Capital10€6.43M€6.50M
Issued capital100€6.43M€6.50M
Outside capital11€332.58M€354.52M
Share premium1100/10€332.58M€354.52M
Profit (loss) carried forward14€-218.17M€-309.08M
Provisions and deferred taxes16€4.20M€2.90M
Provisions for liabilities and charges160/5€4.20M€2.90M
Other liabilities and charges164/5€4.20M€2.90M
Amounts payable17/49€27.23M€57.16M
Amounts payable after more than one year17€11.81M€26.38M
Financial debts170/4€11.81M€26.38M
Subordinated loans170€10.50M€10.85M
Other loans174€1.32M€15.53M
Amounts payable within one year42/48€14.25M€29.71M
Current portion of amounts payable after more than one year42€145k€7.79M
Trade debts44€6.07M€10.54M
Suppliers440/4€6.07M€10.54M
Taxes, remuneration and social security45€2.20M€2.22M
Taxes450/3€183k€351k
Remuneration and social security454/9€2.02M€1.87M
Other amounts payable47/48€5.84M€9.16M
Accrued charges and deferred income492/3€1.16M€1.06M
Income statement Code20242025
Operating income70/76A€9.89M€10.72M
Turnover70€4.53M€8.29M
Change in stocks of work in progress, finished goods and contracts in progress71€133k€-864k
Own construction capitalised72€4.91M€2.95M
Other operating income74€308k€344k
Operating charges60/66A€75.30M€98.93M
Goods for resale, raw materials and consumables60€3.76M€3.21M
Purchases600/8€2.95M€3.64M
Change in stocks: decrease (increase)609€803k€-427k
Services and other goods61€56.60M€82.46M
Remuneration, social security and pensions62€8.46M€7.01M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4.54M€6.22M
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-2.07M€121k
Provisions for liabilities and charges: additions (uses and reversals)635/8€4.02M€-1.31M
Other operating charges640/8€501€24k
Non-recurring operating charges66A-€1.20M
Operating profit (loss)9901€-65.41M€-88.21M
Financial income75/76B€7.62M€3.86M
Recurring financial income75€7.62M€3.86M
Income from financial fixed assets750€309k€253k
Income from current assets751€2.45M€1.37M
Other financial income752/9€4.87M€2.23M
Non-recurring financial income76B-€0
Financial charges65/66B€3.51M€6.66M
Recurring financial charges65€3.51M€6.66M
Debt charges650€538k€1.20M
Other financial charges652/9€2.97M€5.46M
Profit (loss) for the period before taxes9903€-61.29M€-91.01M
Income taxes67/77€-78k€-97k
Taxes670/3-€8k
Tax adjustments and reversals of tax provisions77€78k€105k
Profit (loss) for the period9904€-61.21M€-90.91M
Profit (loss) for the period to be appropriated9905€-61.21M€-90.91M
Appropriation of the result
Profit (loss) to be appropriated9906€-218.17M€-309.08M
Profit (loss) brought forward from the previous period14P€-156.96M€-218.17M
Social balance
Average headcount (FTE)908747.043.1

The notes to these accounts (85 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
31-08
State Gazette act Capital & shares · Miscellaneous
Share issue · Capital increase · Preemptive rights removal4 facts ▸
  • Board meeting, 30-07-2026
  • Share issue, Plan de Droits de Souscription 2026, 1000000
  • Capital increase
  • Preemptive rights removal, émission des droits de souscription, article 7 des statuts et article 7:191 du Code des sociétés et des associations
26-08
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital7 facts ▸
  • Board meeting, 20-08-2026
  • Capital increase, €17.674,02
  • Share issue, actions sans désignation de valeur nominale, 1767402
  • Capital, €7.092.826,33
  • Statutes amendment
  • Power of attorney
  • Power of attorney
22-07
State Gazette act Statutes amendment
Power of attorney · Authorised capital4 facts ▸
  • General meeting, 09/07/2026
  • Statutes amendment
  • Power of attorney, Tim CARNEWAL
  • Authorised capital, 7.075.152,31 EUR
16-07
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Statutes amendment5 facts ▸
  • Board meeting, 30/06/2026
  • Capital increase, €1.465,31
  • Capital, €7.075.152,31
  • Statutes amendment
  • Power of attorney, not specified
13-07
NBB filing Annual accounts filed
fiscal year 2025 · consolidated
13-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
01-07
State Gazette act Reappointments: Robelga SRL, Jürgen Hambrecht and 5 others
Permanent representative: Robert Taub · Approval · Director discharge14 facts ▸
  • General meeting, 10/06/2026
  • Approval, Approbation des comptes annuels pour l'exercice social clôturé au 31 décembre 2025 et de l'affectation du résultat
  • Director discharge, NYXOAH
  • Director discharge, NYXOAH
  • Approval, Approbation de toutes les clauses pertinentes de l’Instrument Obligataire conformément à l'article 7:151 du CSA
  • Director reappointment, Robelga SRL (director)
  • Permanent representative, Robert Taub
  • Director reappointment, Jürgen Hambrecht (independent director)
  • Director reappointment, Kevin Rakin (independent director)
  • Director reappointment, Rita Johnson-Mills (independent director)
  • Director reappointment, Virginia Kirby (independent director)
  • Director reappointment, Daniel Wildman (independent director)
  • +2 further facts in this act
01-07
State Gazette act Capital & shares · Statutes amendment
Capital increase · Bank account · Capital4 facts ▸
  • Capital increase, €6.371,64
  • Bank account, 10 juin 2026
  • Capital, €7.073.687
  • Statutes amendment, 5
30-06
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Share issue5 facts ▸
  • Capital increase, €545.953,94
  • Capital, €7.067.315,36
  • Share issue, 55.232.558, 22.484.472 nominatives, 5.457.448 dématérialisées, 27.290.638 autres (implied from total 55.232.558 - 22.484.472 - 5.457.448? No, text says 49.138.0…
  • Bank account, 09/06/2026
  • Statutes amendment, 5
26-06
State Gazette act Permanent representative: Daniel Wildman
Capital increase · Share issue · Power of attorney13 facts ▸
  • Board meeting, 04/06/2026
  • Capital increase
  • Share issue, Augmentation de capital par Sur-Allocation, option de souscription accordée aux Underwriters, Actions Optionnelles
  • Power of attorney, Rita Johnson-Mills
  • Power of attorney, Virgina Kirby
  • Power of attorney, Wildman Ventures LLC
  • Permanent representative, Daniel Wildman
  • Preemptive rights waiver, Augmentation de Capital et Augmentation de Capital par Sur-Allocation, Underwriters et investisseurs
  • Nominal value, 0.01 EUR
  • Minimum issuance price, 0.1459 EUR
  • Underwriters identification, Bank of America Securities, Inc., Degroof Petercam NV/SA, B. Riley Securities, Inc.
  • Transaction documents approval, Convention de Souscription, Convention de Blocage, Supplément au Prospectus, Convention de Contrôle du Compte Bloqué
  • +1 further facts in this act
02-03
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Statutes amendment4 facts ▸
  • Board meeting, 20-02-2026
  • Capital increase, €6.359,43
  • Capital, €6.511.048,19
  • Statutes amendment
02-01
State Gazette act Miscellaneous
Share issue · Capital increase3 facts ▸
  • Board meeting, 18/12/2025
  • Share issue, 225, 20.519.840,50 EUR versé par virement, 1.980.159,50 EUR libéré via compensation d’une créance
  • Capital increase, €égal au prix de conversion desdites obligations converties
Show earlier events
2025
31-12
Financial Weakest financial yearnet €-90.91M
Net result drops to €-90.91M, the lowest in the series.
01-12
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Statutes amendment4 facts ▸
  • Board meeting, 20/11/2025
  • Capital increase, €2.922,5
  • Capital, €6.504.688,76
  • Statutes amendment
28-11
State Gazette act Capital & shares · Statutes amendment
Approval · Capital increase · Share issue9 facts ▸
  • Board meeting, 18/11/2025
  • Approval, rapport spécial du conseil d’administration
  • Capital increase, €51.894,28
  • Share issue, nouvelles actions de même nature, 5.189.428
  • Capital, €6.501.766,26
  • Statutes amendment
  • Power of attorney, not specified
  • Power of attorney, not specified
  • Waiver of preemptive rights, Suppression du droit de préférence
24-10
State Gazette act Miscellaneous
Share issue · Capital increase · Preemptive rights waiver4 facts ▸
  • Board meeting, 13/10/2025
  • Share issue, plan de droits de souscription 2025-2, droits de souscription
  • Capital increase
  • Preemptive rights waiver, Suppression du droit de préférence à l’occasion de l’émission des droits de souscription, au profit des employés, dirigeants, administrateurs, consultants et co…
22-09
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Statutes amendment6 facts ▸
  • Board meeting, 26/08/2025
  • Capital increase, €17.805,7
  • Capital, €6.449.871,98
  • Statutes amendment
  • Waiver of preemptive rights, Suppression du droit de préférence de chaque actionnaire existant et de chaque titulaire de droits de souscription existants
  • Power of attorney
22-07
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital3 facts ▸
  • Capital increase, €944,9
  • Share issue, nouvelles actions souscrites en espèces
  • Capital, €6.432.066,28
11-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
11-07
NBB filing Annual accounts filed
fiscal year 2024 · consolidated
25-06
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Bank account4 facts ▸
  • Capital increase, €1.095,22
  • Share issue, actions sans désignation de valeur nominale, 6375
  • Bank account, BE67 0689 5615 4487
  • Capital, €6.431.121,38
23-06
State Gazette act Reappointments: Robelga SRL, Jürgen Hambrecht and 6 others
Permanent representatives: Robert Taub, Daniel Wildman and Thomas Meurice · Appointment: Ernst et Young Réviseurs d'Entreprises SRL (statutory auditor) · Approval14 facts ▸
  • General meeting, 11/06/2025
  • Director reappointment, Robelga SRL (director)
  • Permanent representative, Robert Taub
  • Director reappointment, Jürgen Hambrecht (independent director)
  • Director reappointment, Kevin Rakin (independent director)
  • Director reappointment, Rita Johnson-Mills (independent director)
  • Director reappointment, Virginia Kirby (independent director)
  • Director reappointment, Wildman Ventures LLC (independent director)
  • Permanent representative, Daniel Wildman
  • Director reappointment, Pierre Gianello (director)
  • Director reappointment, Olivier Taelman (director)
  • Approval, rémunération du commissaire pour l'exercice social clôturé au 31 décembre 2024
  • +2 further facts in this act
21-05
State Gazette act Capital & shares
Capital increase · Share issue · Capital5 facts ▸
  • Capital increase, €343,6
  • Share issue, actions de même rang et ayant les mêmes droits que les actions existantes
  • Capital, €6.430.026,16
  • Bank account, 09/05/2025
  • Power of attorney, An Moonen
24-04
State Gazette act Miscellaneous
Capital increase · Power of attorney · Preemptive rights waiver6 facts ▸
  • Board meeting, 15/04/2025
  • Capital increase
  • Power of attorney, chaque administrateur de la Société
  • Preemptive rights waiver, ja
  • Subscription period, 60 mois
  • Minimum subscription price, 0,1718 EUR
13-02
State Gazette act Miscellaneous
Share issue · Capital increase · Power of attorney4 facts ▸
  • Board meeting, 30/01/2025
  • Share issue, droits de souscription, 805.000
  • Capital increase
  • Power of attorney, tout administrateur
21-01
State Gazette act Miscellaneous
Approval2 facts ▸
  • General meeting, 19/12/2024
  • Approval, Approbation de toutes les clauses pertinentes des Conventions de la BEI conformément à l'article 7:151 du Code belge des sociétés et des associations
2024
25-11
State Gazette act Capital & shares
Capital increase · Share issue · Bank account7 facts ▸
  • Capital increase, €6.571,35
  • Share issue, actions sans désignation de valeur nominale
  • Bank account, BE77 0689 5374 4342
  • Capital, €6.429.682,56
  • Power of attorney, An Moonen
  • Subscription price, 205.065,00 EUR
  • Share payment, Belfius, 100%
24-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €515.400
  • Share issue, actions sans désignation de valeur nominale, 3.000.000
  • Capital, €6.423.111,21
  • Bank account, 09/10/2024
01-10
State Gazette act Capital & shares
Capital increase · Share issue · Capital5 facts ▸
  • Capital increase, €386,55
  • Share issue, actions sans désignation de valeur nominale
  • Capital, €5.907.711,21
  • Power of attorney, An Moonen
  • Bank account, 24/09/2024
12-09
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Bank account9 facts ▸
  • Capital increase, €2.362,25
  • Share issue, actions de même rang et ayant les mêmes droits que les actions existantes
  • Bank account, BE59 0689 5315 1026
  • Capital, €5.907.324,66
  • Exercise price, 5,42 EUR
  • Subscription rights reference, Tim CARNEWAL, ESOP 2021
  • Bank attestation, 02/09/2024
  • Statutes amendment, 5
  • Accounting allocation per share, 0,1718 EUR, Capital
07-08
State Gazette act Miscellaneous
Share issue · Capital increase · Power of attorney4 facts ▸
  • Board meeting, 31/07/2024
  • Share issue, droits de souscription, 1.000.000
  • Capital increase
  • Power of attorney, tout administrateur
08-07
NBB filing Annual accounts filed
fiscal year 2023 · consolidated
08-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
01-07
State Gazette act Capital & shares
Capital increase · Share issue · Capital5 facts ▸
  • Capital increase, €2.168,98
  • Share issue, actions de même rang et ayant les mêmes droits que les actions existantes
  • Capital, €5.904.962,41
  • Bank account, 20/06/2024
  • Power of attorney, An Moonen
24-06
State Gazette act Appointment: Robelga SRL (director)
Permanent representatives: Robert Taub and Daniel Wildman · Reappointments: Jürgen Hambrecht, Kevin Rakin and 5 others · Statutes amendment12 facts ▸
  • General meeting, 12/06/2024
  • Director appointment, Robelga SRL (director)
  • Permanent representative, Robert Taub
  • Director reappointment, Jürgen Hambrecht (independent director)
  • Director reappointment, Kevin Rakin (independent director)
  • Director reappointment, Rita Johnson-Mills (independent director)
  • Director reappointment, Virginia Kirby (independent director)
  • Director reappointment, Wildman Ventures LLC (independent director)
  • Permanent representative, Daniel Wildman
  • Director reappointment, Pierre Gianello (director)
  • Director reappointment, Olivier Taelman (director)
  • Statutes amendment
12-06
State Gazette act Capital & shares
Capital increase · Capital · Share issue5 facts ▸
  • Capital increase, €51.540
  • Capital, €5.902.793,43
  • Share issue, nominative, Actions Optionnelles
  • Bank account, 03/06/2024
  • Statutes amendment, Article 5
10-06
State Gazette act Capital & shares
Capital increase · Capital · Share issue5 facts ▸
  • Capital increase, €923.382,91
  • Capital, €5.851.253,43
  • Share issue, 5374755, 3964048
  • Statutes amendment
  • Atm condition, Condition Résolutoire ATM non satisfaite, Réduction ATM définitive
03-06
State Gazette act Permanent representative: Daniel Wildman
Capital increase · Power of attorney · Capital authorized reduction9 facts ▸
  • Board meeting, 22/05/2024
  • Capital increase
  • Capital increase
  • Power of attorney
  • Power of attorney, chaque administrateur de la Société
  • Permanent representative, Daniel Wildman
  • Capital authorized reduction, Réduction du montant maximum de l'augmentation de capital conditionnelle ATM
  • Pre-emptive rights, Augmentation de Capital et Augmentation de Capital par Sur-Allocation, suppression
  • Admission to trading, NYXH
23-04
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €515,4
  • Share issue, actions, 3000
  • Capital, €4.927.870,52
  • Bank account, 15 avril 2024
25-03
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Bank account4 facts ▸
  • Capital increase, €1.486,07
  • Share issue, actions de même rang et ayant les mêmes droits que les actions existantes
  • Bank account, BE19 0689 5162 6712
  • Capital, €4.927.355,12
2023
13-09
NBB filing Annual accounts filed
fiscal year 2022 · consolidated
05-09
State Gazette act Capital & shares
Capital increase · Share issue · Capital5 facts ▸
  • Capital increase, €1.718
  • Share issue, 10000, exercice de droits de souscription ESOP 2016
  • Capital, €4.925.869,05
  • Bank account, 25 août 2023
  • Power of attorney, An Moonen
27-07
State Gazette act Capital & shares
Capital increase · Share issue · Bank account5 facts ▸
  • Capital increase, €343,6
  • Share issue, nouvelles actions, 2000
  • Bank account, 13 juillet 2023
  • Capital, €4.924.151,05
  • Power of attorney, An Moonen
13-07
NBB filing Annual accounts filed
fiscal year 2022 · full schema
21-04
State Gazette act Capital & shares
Capital increase · Share issue · Capital3 facts ▸
  • Capital increase, €64.425
  • Share issue, actions sans désignation de valeur nominale
  • Capital, €4.923.807,45
14-04
State Gazette act Capital & shares
Capital increase · Share issue · Bank account6 facts ▸
  • Board meeting, 30/03/2023
  • Capital increase, €351.768,06
  • Share issue, nouvelles actions, 2.047.544
  • Bank account, 30 mars 2023
  • Capital, €4.859.382,45
  • Statutes amendment, 5
04-04
State Gazette act Capital & shares
Capital increase · Share issue · Capital3 facts ▸
  • Capital increase, €67.545,23
  • Share issue, nouvelles actions à émettre ... de même nature et ayant les mêmes droits que les actions existantes
  • Capital, €4.507.614,39
27-03
State Gazette act Appointment: Wildman Ventures LLC (director)
Permanent representative: Daniel Wildman · Resignation: Raymond Cohen (director)4 facts ▸
  • Board meeting, 08/01/2023
  • Director appointment, Wildman Ventures LLC (director)
  • Permanent representative, Daniel Wildman
  • Director resignation, Raymond Cohen (director)
22-03
State Gazette act Miscellaneous
Statutes amendment · Power of attorney4 facts ▸
  • Board meeting, 15/03/2023
  • Statutes amendment
  • Statutes amendment
  • Power of attorney, tout administrateur
11-01
State Gazette act Resignation: Ray COHEN (director)
Share issue · Capital increase · Power of attorney6 facts ▸
  • Board meeting, 28/12/2022
  • Share issue, droits de souscription, 700.000
  • Capital increase
  • Director resignation, Ray COHEN (director)
  • Power of attorney, tout administrateur
  • Preemptive rights waiver, Suppression du droit de préférence à l’occasion de l’émission des droits de souscription
05-01
State Gazette act Miscellaneous
Capital increase · Power of attorney · Preemptive rights suppression4 facts ▸
  • Board meeting, 22/12/2022
  • Capital increase
  • Power of attorney, chaque administrateur de la Société
  • Preemptive rights suppression, ja
04-01
NBB filing Annual accounts filed
fiscal year 2021 · consolidated
2022
12-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €1.718
  • Share issue, nouvelles actions... attribuées aux détenteurs de droits de souscription
  • Capital, €4.440.069,16
  • Bank account, 29 septembre 2022
16-08
State Gazette act Resignations: Donald Deyo (director) and Jan Janssen (director)
Appointments: Rita Johnson-Mills, Virginia M. Kirby and 2 others · Approval · Director discharge15 facts ▸
  • General meeting, 08/06/2022
  • Approval, comptes annuels et consolidés pour l'exercice social clôturé au 31 décembre 2021
  • Director discharge, NYXOAH
  • Director discharge, NYXOAH
  • Director resignation, Donald Deyo (director)
  • Director resignation, Jan Janssen (director)
  • Director appointment, Rita Johnson-Mills (independent director)
  • Director appointment, Virginia M. Kirby (independent director)
  • Director appointment, Raymond W. Cohen (independent director)
  • Auditor appointment, Ernst & Young Réviseurs d'Entreprises SRL (statutory auditor)
  • Capital increase, €6.686,47
  • Bank account, BE81 0689 4223 8324
  • +3 further facts in this act
15-07
NBB filing Annual accounts filed
fiscal year 2021 · full schema
18-02
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €4.295
  • Share issue, actions de même rang et ayant les mêmes droits que les actions existantes
  • Capital, €4.431.664,69
  • Bank account, 09/02/2022
2021
06-12
State Gazette act Capital & shares
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €4.295
  • Share issue, actions de même rang et ayant les mêmes droits que les actions existantes
  • Capital, €4.427.369,69
  • Power of attorney, An Moonen
24-11
State Gazette act Capital & shares · Statutes amendment
Share issue · Capital increase · Capital5 facts ▸
  • Share issue, actions de même rang et ayant les mêmes droits que les actions existantes
  • Capital increase, €15.462
  • Capital, €4.423.074,69
  • Bank account, BE81 0689 4223 8324
  • Power of attorney, An Moonen
03-11
State Gazette act Capital & shares · Statutes amendment
Share issue · Capital increase · Capital6 facts ▸
  • Share issue, 27000, exercice de 54 droits de souscription ESOP 2016
  • Capital increase, €4.638,6
  • Capital, €4.388.714,69
  • Bank account, BE81 0689 4223 8324
  • Power of attorney, Berquin Notaires
  • Power of attorney, An Moonen
12-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital5 facts ▸
  • Capital increase, €14.173,5
  • Share issue, actions de même rang et ayant les mêmes droits que les actions existantes
  • Capital, €4.384.076,09
  • Bank account, BE81 0689 4223 8324
  • Power of attorney, An Moonen
04-10
State Gazette act Resignation: Janke Dittmer (director)
Appointment: Rita Johnson-Mills (director) · Share issue · Capital increase5 facts ▸
  • Board meeting, 08/09/2021
  • Director resignation, Janke Dittmer (director)
  • Director appointment, Rita Johnson-Mills (director)
  • Share issue, droits de souscription, 1.400.000
  • Capital increase
28-09
State Gazette act Resignation: Janke Dittmer (director)
Capital increase · Capital · Share issue5 facts ▸
  • Capital increase, €487.053
  • Capital, €4.295.126,64
  • Share issue, nominative, Actions Offertes
  • Director resignation, Janke Dittmer (director)
  • Statutes amendment
09-09
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment7 facts ▸
  • Capital increase, €73.057,95
  • Capital increase, €1.718
  • Capital, €4.369.902,59
  • Statutes amendment
  • Bank account, Belfius
  • Bank account, Belfius Banque
  • Share form, nominative
27-07
State Gazette act Resignation: Janke Dittmer (director)
Capital increase · Power of attorney · Preemptive rights cancellation9 facts ▸
  • Board meeting, 23/06/2021
  • Capital increase, €687.141,97
  • Capital increase, €103.071,29
  • Director resignation, Janke Dittmer (director)
  • Power of attorney, chaque administrateur de la Société
  • Preemptive rights cancellation, Suppression à tout droit de préférence
  • Delegation of powers, détermination de toutes les modalités et conditions de l'Augmentation de Capital et de l'Augmentation de Capital par Sur-Allocation, notamment prix, nombre d'ac…
  • Approval of codes and policies, sous réserve de la réalisation de l'Offre et avec effet à la date de la détermination finale du Prix d'Emission
  • Statutes amendment
23-07
State Gazette act Capital & shares
Capital increase · Share issue · Capital6 facts ▸
  • Capital increase, €10.308
  • Share issue, nouvelles actions ... suite à l'exercice de droits de souscription
  • Capital, €3.808.073,64
  • Bank account, BE46 0689 4164 7836
  • Power of attorney, Berquin Notaires
  • Power of attorney, An Moonen
2020
31-12
Financial Liquidity times 7current ratio 19.96
Current ratio from 2.78 to 19.96.
31-12
Financial Equity above €100MEq €105.77M ▲1392%
Equity rises from €7.09M to €105.77M.
09-12
State Gazette act Appointment: Carlo-Sébastien D'Addario (représentant du commissaire)
Resignation: Vincent Etienne (représentant du commissaire)3 facts ▸
  • General meeting, 23/07/2020
  • Director appointment, Carlo-Sébastien D'Addario (représentant du commissaire)
  • Director resignation, Vincent Etienne (représentant du commissaire)
10-11
State Gazette act Resignation: MedTech Execs LLC (director)
Appointments: Donald Deyo, Robert Taub and 7 others · Capital increase · Bank account18 facts ▸
  • General meeting, 07/09/2020
  • Capital increase, €744.753
  • Bank account, BE94 0689 3828 9414
  • Share issue, droit de souscription de surallocation, Belfius Bank
  • Capital increase, €11.228,68
  • Capital, €3.680.297,39
  • Statutes amendment
  • Director resignation, MedTech Execs LLC (director)
  • Director appointment, Donald Deyo (director)
  • Director appointment, Robert Taub (administrateur non exécutif)
  • Director appointment, Janke Dittmer (administrateur non exécutif)
  • Director appointment, Kevin Lance Rakin (administrateur non exécutif indépendant)
  • +6 further facts in this act
09-11
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Bank account5 facts ▸
  • Capital increase, €4.037,3
  • Share issue, nouvelles actions de même rang et ayant les mêmes droits que les actions existantes
  • Bank account, BE71 3632 0535 1969
  • Capital, €3.796.047,64
  • Power of attorney, NautaDutilh SRL
28-10
State Gazette act Capital & shares
Bank account · Capital increase · Capital4 facts ▸
  • Bank account, BE94 0689 3828 9414
  • Capital increase, €111.712,95
  • Capital, €3.792.010,34
  • Share issue, dématérialisée, actions ordinaires
07-10
State Gazette act Resignation: MedTech Execs LLC (director)
Appointments: Donald Deyo, Jürgen Hambrecht and 2 others · Reappointments: Robert Taub, Janke Dittmer and 2 others · Capital increase20 facts ▸
  • General meeting, 07/09/2020
  • Capital increase
  • Share issue, prix d'émission final, Warrant de Sur-allocation
  • Capital increase, €1.000.000
  • Director resignation, MedTech Execs LLC (director)
  • Director discharge, MedTech Execs LLC (director)
  • Director appointment, Donald Deyo (director)
  • Director reappointment, Robert Taub (director)
  • Director reappointment, Janke Dittmer (director)
  • Director reappointment, Kevin Rakin (director)
  • Director appointment, Jürgen Hambrecht (director)
  • Director appointment, Pierre Gianello (director)
  • +8 further facts in this act
16-09
State Gazette act Capital & shares
Capital increase · Bank account · Capital4 facts ▸
  • Capital increase, €7.645,1
  • Bank account, 3631 2245 8395
  • Capital, €2.924.315,71
  • Power of attorney, NautaDutilh SRL
16-04
State Gazette act Reappointment: Pierre Gianello (director)
Appointments: MedTech Execs LLC, Ernst & Young Réviseurs d'Entreprises SCRL and Olivier Taelman · Permanent representatives: Donald L. Deyo and Etlenne Vincent · Resignations: Donald L. Deyo, Christopher Smith and 3 others15 facts ▸
  • General meeting, 23/05/2019
  • Director reappointment, Pierre Gianello (director)
  • Director appointment, MedTech Execs LLC (independent director)
  • Permanent representative, Donald L. Deyo
  • Auditor appointment, Ernst & Young Réviseurs d'Entreprises SCRL (statutory auditor)
  • Permanent representative, Etlenne Vincent
  • Board meeting, 27/05/2019
  • Director resignation, Donald L. Deyo (director)
  • Board meeting, 10/09/2019
  • Director resignation, Christopher Smith (director)
  • Director resignation, MINV SA (director)
  • Director resignation, Robert Taub (day-to-day manager)
  • +3 further facts in this act
23-03
State Gazette act Capital & shares · Statutes amendment
Capital · Capital increase · Bank account13 facts ▸
  • General meeting, 21/02/2020
  • Capital, €2.481.298,61
  • Capital increase, €435.372
  • Bank account, BE66 3631 9726 9243
  • Capital, €2.916.670,61
  • Share split, Result of share split (ratio 500:1) on 33,958 shares, 16979000
  • Capital, €2.916.670,61
  • Subscription right issue, Warrants issued free of charge, Droits de Souscription ESOP
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Conditional capital increase, Capital increase to be determined based on exercise price multiplied by number of exercised warrants, as per Plan de Warrants 2020, exercise of ESOP warrants
  • +1 further facts in this act
93.3% of this act was read; anything after the cut is not in this list.Read the act at the Belgisch Staatsblad ↗
2019
16-05
State Gazette act Appointment: Pierre Gianello (class A director)
Resignation: Jurgen Hambrecht (class A director)4 facts ▸
  • General meeting, 03-05-2018
  • Director appointment, Pierre Gianello (class A director)
  • Board meeting, 27-03-2018
  • Director resignation, Jurgen Hambrecht (class A director)
09-01
State Gazette act Capital & shares
Share issue · Capital increase3 facts ▸
  • General meeting, 12/12/2018
  • Share issue, droits de souscription, 525
  • Capital increase
2018
04-12
State Gazette act Appointment: Jan Janssen (director)
Capital increase · Capital · Bank account6 facts ▸
  • General meeting, 05/10/2018
  • Capital increase, €318.028,88
  • Capital, €2.481.298,61
  • Bank account, 10.001.403,88, EUR
  • Director appointment, Jan Janssen (director)
  • Share issue, Droits de Souscription Anti-Dilution de Catégorie B2, Cochlear Investments PTY LTD
05-11
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital15 facts ▸
  • General meeting, 05/10/2018
  • Capital increase, €477.043,32
  • Share issue, Actions Préférentielles de Catégorie B2, 1534
  • Share issue, Droits de Souscription Anti-Dilution de Catégorie B2, 10
  • Capital, €2.163.269,73
  • Statutes amendment
  • Power of attorney, Sophie Maquet
  • Power of attorney, chaque administrateur
  • Subscription period, 14/12/2018
  • Power of attorney, chaque administrateur
  • Power of attorney, chaque administrateur
  • Waiver, renonciation à l'envoi de la lettre recommandée visée à l'article 593 du Code des sociétés
  • +3 further facts in this act
07-06
State Gazette act Appointment: Christopher Smith (independent director)
Statutes amendment · Mandate compensation · Power of attorney5 facts ▸
  • General meeting, 03/05/2018
  • Statutes amendment
  • Director appointment, Christopher Smith (independent director)
  • Mandate compensation, Christopher Smith
  • Power of attorney, Sophie Maquet
2016
25-11
State Gazette act Appointment: Ernst et Young Réviseurs d'Entreprises SC SCRL (statutory auditor)
Permanent representative: Vincent Etienne · Share issue · Capital increase9 facts ▸
  • General meeting, 03/11/2016
  • Share issue, 1500, sous condition suspensive de et dans la mesure où ces droits de souscription sont octroyés par le conseil d'administration et leur acceptation
  • Capital increase
  • Auditor appointment, Ernst et Young Réviseurs d'Entreprises SC SCRL (statutory auditor)
  • Permanent representative, Vincent Etienne
  • Registered-office move, Rue Edouard Belin 12, 1435 Mont-Saint-Guibert
  • Power of attorney, Sophie MAQUET
  • Power of attorney, conseil d'administration
  • Power of attorney, administrateurs
10-11
State Gazette act Appointment: Enrique Vega (daily management delegate)
3 facts ▸
  • Board meeting, 16/09/2016
  • Director appointment, Enrique Vega (daily management delegate)
  • Director appointment, Enrique Vega (ceo)
17-08
State Gazette act Resignations: Uwe Wascher (director) and Bernard Jolly (director)
Appointments: Jürgen Hambrecht, Janke Dittmer and 3 others · Capital increase · Share issue16 facts ▸
  • General meeting, 29/06/2016
  • Capital increase, €719.224,5
  • Share issue, Actions Préférentielles de Catégorie B, 7032
  • Share issue, Droits de souscription, 230
  • Capital, €2.004.255,29
  • Statutes amendment
  • Director resignation, Uwe Wascher (director)
  • Director resignation, Bernard Jolly (director)
  • Director appointment, Jürgen Hambrecht (class A director)
  • Director appointment, Janke Dittmer (class B director)
  • Director appointment, Don Deyo (independent director)
  • Director appointment, Kevin Rakin (independent director)
  • +4 further facts in this act
17-02
State Gazette act Capital & shares · Miscellaneous
Statutes amendment1 fact ▸
  • Statutes amendment
2015
16-11
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment4 facts ▸
  • General meeting, 22/10/2015
  • Capital increase, €217.549,56
  • Capital, €1.285.030,79
  • Statutes amendment
12-11
State Gazette act Reappointments: TAUB ROBERT (managing director) and MASHIACH ADI (director)
Resignation: MASHIACH ADI (director)5 facts ▸
  • General meeting, 15/04/2015
  • Director reappointment, TAUB ROBERT (managing director)
  • Director reappointment, MASHIACH ADI (director)
  • General meeting, 22/07/2015
  • Director resignation, MASHIACH ADI (director)
08-10
State Gazette act Miscellaneous
Statutes amendment1 fact ▸
  • Statutes amendment
19-03
State Gazette act Capital & shares · Resignations & appointments
Share issue · Capital increase · Power of attorney7 facts ▸
  • General meeting, 23/12/2014
  • Share issue, warrants, 300
  • Capital increase
  • Power of attorney, le conseil d'administration
  • Warrant condition, dix (10) ans
  • Warrant condition, octroyés gratuitement aux bénéficiaires
  • Warrant allocation, attribués à la présente société NYXOAH
2014
21-08
State Gazette act Capital & shares
Share issue · Capital increase · Bank account5 facts ▸
  • Share issue, actions nominatives, 3
  • Capital increase, €306,84
  • Bank account, BE 79 7320 3345 3533
  • Capital, €1.067.481,23
  • Statutes amendment
19-06
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital10 facts ▸
  • Board meeting, 06/05/2014
  • Capital increase, €480.409,16
  • Share issue, actions ordinaires, 2064
  • Share issue, actions ordinaires, 2064
  • Share issue, actions ordinaires, 16
  • Share issue, actions ordinaires, 553
  • Capital, €869.364,87
  • Statutes amendment
  • Conversion, 4697, 1500
  • Power of attorney, Pascal WEERTS
19-06
State Gazette act Appointment: Bernard JOLLY (director)
Capital increase · Capital · Statutes amendment5 facts ▸
  • General meeting, 16/05/2014
  • Capital increase, €197.809,52
  • Capital, €1.067.174,39
  • Statutes amendment
  • Director appointment, Bernard JOLLY (director)
28-02
State Gazette act Capital & shares · Statutes amendment
Share issue · Power of attorney · Loan cancellation6 facts ▸
  • General meeting, 30/12/2013
  • Share issue, Emission de 1.500 obligations convertibles assorties de warrants
  • Share issue, Emission de 200 obligations convertibles assorties de warrants
  • Share issue, Emission de 8.804 droits de souscription
  • Power of attorney
  • Loan cancellation, Résiliation de l'emprunt obligataire convertible subordonné du 5 novembre 2012
2013
18-06
State Gazette act Capital & shares
Share issue · Capital increase · Warrant price6 facts ▸
  • General meeting, 03/05/2013
  • Share issue, droits de souscription, 340
  • Capital increase
  • Warrant price, 1 EUR
  • Warrant deadline, 02/05/2023
  • Waiver, droit de souscription préférentielle
25-04
State Gazette act Capital & shares · Resignations & appointments
Capital decrease · Capital · Power of attorney5 facts ▸
  • General meeting, 30/03/2013
  • Capital decrease, €2.559.558,52
  • Capital, €388.955,71
  • Power of attorney, Patrick della FAILLE
  • Power of attorney, Marie PIRARD
05-04
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Power of attorney5 facts ▸
  • General meeting, 06/03/2013
  • Capital increase, €58.147,5
  • Capital increase, €244.994,8
  • Capital, €2.948.514,23
  • Power of attorney, deux administrateurs
2012
03-12
State Gazette act Miscellaneous
Capital increase · Capital decrease · Capital9 facts ▸
  • General meeting, 05/11/2012
  • Capital increase, €10.939,5
  • Capital increase, €989.060,5
  • Capital increase, €145.848
  • Capital increase, €2.604.152
  • Capital decrease, €1.166.628,07
  • Capital, €2.645.371,93
  • Share issue, 1500, 7.500.000,00 EUR
  • Statutes amendment
10-10
State Gazette act Capital & shares · Statutes amendment
Capital decrease · Capital · Statutes amendment6 facts ▸
  • General meeting, 30/08/2012
  • Capital decrease, €1.166.628,07
  • Capital, €2.645.371,93
  • Statutes amendment
  • Power of attorney, NYXOAH
  • Power of attorney, Dimitri CLEENEWERCK de CRAYENCOUR
30-08
State Gazette act Resignation: MINV (director)
Appointment: Wascher Uwe (director) · Mandate compensation4 facts ▸
  • General meeting, 10/06/2011
  • Director resignation, MINV (director)
  • Director appointment, Wascher Uwe (director)
  • Mandate compensation, Wascher Uwe
08-06
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital3 facts ▸
  • General meeting, 27/04/2012
  • Capital increase, €2.750.000
  • Capital, €3.812.000
2011
01-04
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Statutes amendment7 facts ▸
  • General meeting, 08/03/2011
  • Capital increase, €93.000
  • Capital increase, €907.000
  • Capital, €1.062.000
  • Statutes amendment
  • Share split, 2550, 1 à 8,50
  • Waiver of preemptive rights, 1.000.000,00 €
2010
17-06
State Gazette act Registered office
Registered-office move2 facts ▸
  • Board meeting, 31/05/2010
  • Registered-office move, Rue Fond Cattelain 2 B-1435 Mont-St-Guibert
2009
02-09
State Gazette act Registered office
Registered-office move2 facts ▸
  • Board meeting, 21/08/2009
  • Registered-office move, Avenue Blücher 63, 1180 Uccle, Belgique
17-07
State Gazette act Incorporation
Appointments: Robert TAUB, MINV and Adi MASHIACH · Permanent representative: Robert TAUB · Founder10 facts ▸
  • Incorporation, 14 juillet 2009
  • Founder, Robert TAUB
  • Founder, Adi MASHIACH
  • Founding capital, €62.000
  • Director appointment, Robert TAUB (director)
  • Director appointment, MINV (director)
  • Director appointment, Adi MASHIACH (director)
  • Permanent representative, Robert TAUB
  • Director appointment, Robert TAUB (daily management delegate)
  • First general meeting, 1er avril 2011
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
15 directors, last change in 2024
Robelga SRL
Director · since 12-06-2024 · Legal entity · perm. rep.: Robert Taub
Current
Virginia Kirby
Independent director · since 12-06-2024
Current
Wildman Ventures LLC
Independent director · since 08-01-2023 · Legal entity · perm. rep.: Daniel Wildman
Current
Raymond W. Cohen
Independent director · since 08-06-2022
Current
Virginia M. Kirby
Independent director · since 08-06-2022
Current
Rita Johnson-Mills
Independent director · since 27-08-2021
Current
9 other directors
Donald Lester Deyo
Administrateur non exécutif indépendant · since 21-09-2020
Current
Kevin Lance Rakin
Administrateur non exécutif indépendant · since 21-09-2020
Current
Jürgen Hambrecht
Independent director · since 07-09-2020
Current
Robert Taub
Administrateur non exécutif · since 07-09-2020
Current
Olivier Taelman
Director · since 30-11-2019
Current
GIANELLO, Pierre
Director · since 03-05-2018
Current
Kevin Rakin
Independent director · since 29-06-2016
Current
Daniel Wildman
Independent director
Current
Don Deyo
Independent director · since 29-06-2016
Not recently confirmed
12-06-2024 Robelga SRL: Appointed as Director
12-06-2024 Virginia Kirby: Mandate renewed as Independent director
12-06-2024 Wildman Ventures LLC: Mandate renewed as Independent director
12-06-2024 Rita Johnson-Mills: Mandate renewed as Independent director
12-06-2024 Jürgen Hambrecht: Mandate renewed as Independent director
Full history in the Timeline (69 changes) →
Not every act has been read: a resignation may be missing here
1 act was read only in part. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Mont-Saint-Guibert · 3 establishment units since 2009
establishment 2 of 3 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue Edouard Belin 121435 Mont-Saint-Guibert
Ground area
2.9 ha
Building footprint
3,236 m²
Volume, LiDAR
22,127 m³
2 parcels, Wallonia · tallest building 7.5 m, ±2 floors. Linked by address, not a title deed.
3 establishment units
NYXOAH
Rue Edouard Belin 12, 1435 Mont-Saint-GuibertManufacture of medical and dental instruments and supplies
since 20092.180.806.062
Nyxoah Milmort
Rue Haute Claire 1, 4041 HerstalWholesale of pharmaceutical and medical goods
since 20202.318.656.623
Boulevard de Patience et Beaujonc 3, 4000 Liège
Manufacture of medical and dental instruments and supplies
since 20252.384.232.383
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62042B0366/00B003 Wallonia 1.9 ha - -
62071B0791/00X002 Wallonia 1.0 ha 1 · 3,235 m² 7.5 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via establishment units: 2
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
Ernst et Young Reviseurs d'EntreprisesCurrent
Statutory auditor · represented by Thomas Meurice
16-08-2022 → present
Show 2 earlier auditors
Ernst et Young Réviseurs d'Entreprises SC SCRL
Statutory auditor · represented by Vincent Etienne
succeeded by SCRL Ernst & Young Réviseurs d'Entreprises in 2020
25-11-2016 → 16-04-2020
SCRL Ernst & Young Réviseurs d'Entreprises
Statutory auditor · represented by Etlenne Vincent
succeeded by Ernst et Young Reviseurs d'Entreprises in 2022
16-04-2020 → 16-08-2022

Articles of association

Purpose
La société a pour objet, tant en Belgique qu'à l'étranger, en son propre nom et pour son propre compte, la recherche et le développement, la fabrication et la vente d'équipements…
Full purpose

La société a pour objet, tant en Belgique qu'à l'étranger, en son propre nom et pour son propre compte, la recherche et le développement, la fabrication et la vente d'équipements médicaux.

Structure & network

Connections & network

19 connected companies
GIANELLO, Pierre, Shared director, links 12 companies GPGIANELLO, PierreBRUSSELS LIFE SCIENCE INCUBATOR, via GIANELLO, Pierre BLBRUSSELS LIFESCIENCE…CENTRE CHAPELLE-AUX-CHAMPS, via GIANELLO, Pierre CCCENTRECHAPELLE-AUX-…CENTRE HOSPITALIER NEUROLOGIQUE WILLIAM LENNOX, via GIANELLO, Pierre CHCENTREHOSPITALIER…Cliniques de l'Europe - Europa Ziekenhuizen, via GIANELLO, Pierre CDCliniques del'Europe…Cliniques universitaires Saint-Luc, via GIANELLO, Pierre CUCliniquesuniversitaires…de Duve Institute, via GIANELLO, Pierre DDde DuveInstituteFondation Saint - Luc, via GIANELLO, Pierre FSFondationSaint - LucService de Santé mentale @Le Méridien@, via GIANELLO, Pierre SDService deSanté mentale…Service Santé mentale Le Chien Vert, via GIANELLO, Pierre SSService Santémentale Le…Services de Santé Mentale de l'UCL à Bruxelles, via GIANELLO, Pierre SDServices deSanté Mentale…SOPARTEC, via GIANELLO, Pierre SSOPARTECUniversité Catholique de Louvain, via GIANELLO, Pierre UCUniversitéCatholique de…CHENICLEM, Shared director CCHENICLEMNYXOAH NYXOAH0817.149.675
Shared directors
Linked via shared directors
Show 15 more companies with a shared director
former
former
SOPARTEC
via GIANELLO, Pierre · Director
former
former
CHENICLEM
Shared director
IP Trade
Shared director
NOMAINVEST
Shared director
Science Europe
Shared director

Capital and shareholders

Shareholders according to the acts
After the capital increase act of 16-08-2022 ↗
  • Robert Taub 5,560 shares · 955.21 EUR
  • Kevin Rakin 5,560 shares · 955.21 EUR
  • Jürgen Hambrecht 5,560 shares · 955.21 EUR
  • Rita Johnson-Mills 5,560 shares · 955.21 EUR
  • Pierre Gianello 5,560 shares · 955.21 EUR
  • Raymond W. Cohen 5,560 shares · 955.21 EUR
  • Virginia M. Kirby 5,560 shares · 955.21 EUR
After the capital increase act of 08-06-2012 ↗
At incorporation act of 17-07-2009 ↗

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 26-08-2026 Capital increase of 17,674.02 EUR · to 7,092,826.33 EUR · in kind
  2. 16-07-2026 Capital increase of 1,465.31 EUR · to 7,075,152.31 EUR · 146,531 new shares
  3. 01-07-2026 Capital increase of 6,371.64 EUR · to 7,073,687 EUR
  4. 30-06-2026 Capital increase of 545,953.94 EUR · to 7,067,315.36 EUR
  5. 02-03-2026 Capital increase of 6,359.43 EUR · to 6,511,048.19 EUR · 635,943 new shares · in kind
  6. 01-12-2025 Capital increase of 2,922.50 EUR · to 6,504,688.76 EUR · 292,250 new shares
  7. 28-11-2025 Capital increase of 51,894.28 EUR · to 6,501,766.26 EUR
  8. 22-09-2025 Capital increase of 17,805.70 EUR · to 6,449,871.98 EUR
Show 57 older capital entries
  1. 22-07-2025 Capital increase of 944.90 EUR · to 6,432,066.28 EUR · 5,500 new shares
  2. 25-06-2025 Capital increase of 1,095.22 EUR · to 6,431,121.38 EUR · 6,375 new shares
  3. 21-05-2025 Capital increase of 343.60 EUR · to 6,430,026.16 EUR · 2,000 new shares
  4. 25-11-2024 Capital increase of 6,571.35 EUR · to 6,429,682.56 EUR · 38,250 new shares
  5. 24-10-2024 Capital increase of 515,400 EUR · to 6,423,111.21 EUR
  6. 01-10-2024 Capital increase of 386.55 EUR · to 5,907,711.21 EUR · 2,250 new shares
  7. 12-09-2024 Capital increase of 2,362.25 EUR · to 5,907,324.66 EUR · 13,750 new shares
  8. 01-07-2024 Capital increase of 2,168.98 EUR · to 5,904,962.41 EUR · 12,625 new shares
  9. 12-06-2024 Capital increase of 51,540 EUR · to 5,902,793.43 EUR · 300,000 new shares · in cash
  10. 10-06-2024 Capital increase of 923,382.91 EUR · to 5,851,253.43 EUR · 5,374,755 new shares
  11. 23-04-2024 Capital increase of 515.40 EUR · to 4,927,870.52 EUR · 3,000 new shares
  12. 25-03-2024 Capital increase of 1,486.07 EUR · to 4,927,355.12 EUR · 8,650 new shares
  13. 05-09-2023 Capital increase of 1,718 EUR · to 4,925,869.05 EUR · 10,000 new shares
  14. 27-07-2023 Capital increase of 343.60 EUR · to 4,924,151.05 EUR · 2,000 new shares
  15. 21-04-2023 Capital increase of 64,425 EUR · to 4,923,807.45 EUR · 375,000 new shares
  16. 14-04-2023 Capital increase of 351,768.06 EUR · to 4,859,382.45 EUR
  17. 04-04-2023 Capital increase of 67,545.23 EUR · to 4,507,614.39 EUR · 393,162 new shares
  18. 12-10-2022 Capital increase of 1,718 EUR · to 4,440,069.16 EUR · 10,000 new shares
  19. 16-08-2022 Capital increase of 6,686.47 EUR · to 4,438,351.16 EUR · 38,920 new shares
  20. 18-02-2022 Capital increase of 4,295 EUR · to 4,431,664.69 EUR · 25,000 new shares
  21. 06-12-2021 Capital increase of 4,295 EUR · to 4,427,369.69 EUR · 25,000 new shares
  22. 24-11-2021 Capital increase of 15,462 EUR · to 4,423,074.69 EUR
  23. 03-11-2021 Capital increase of 4,638.60 EUR · to 4,388,714.69 EUR
  24. 12-10-2021 Capital increase of 14,173.50 EUR · to 4,384,076.09 EUR · 82,500 new shares
  25. 28-09-2021 Capital increase of 487,053 EUR · to 4,295,126.64 EUR
  26. 09-09-2021 Capital increase of 73,057.95 EUR · to 4,368,184.59 EUR · 425,250 new shares
  27. 09-09-2021 Capital increase of 1,718 EUR · to 4,369,902.59 EUR · 10,000 new shares
  28. 27-07-2021 Capital increase of 687,141.97 EUR
  29. 27-07-2021 Capital increase of 103,071.29 EUR
  30. 23-07-2021 Capital increase of 10,308 EUR · to 3,808,073.64 EUR · 60,000 new shares
  31. 10-11-2020 Capital increase of 744,753 EUR · to 3,669,068.71 EUR
  32. 10-11-2020 Capital increase of 11,228.68 EUR · to 3,680,297.39 EUR · in kind
  33. 09-11-2020 Capital increase of 4,037.30 EUR · to 3,796,047.64 EUR · 23,500 new shares
  34. 28-10-2020 Capital increase of 111,712.95 EUR · to 3,792,010.34 EUR · 650,250 new shares
  35. 07-10-2020 Capital increase of 1,000,000 EUR
  36. 16-09-2020 Capital increase of 7,645.10 EUR · to 2,924,315.71 EUR · 44,500 new shares
  37. 23-03-2020 Capital increase of 435,372 EUR · to 2,916,670.61 EUR · 4,200 new shares
  38. 04-12-2018 Capital increase of 318,028.88 EUR · to 2,481,298.61 EUR · 3,068 new shares
  39. 05-11-2018 Capital increase of 477,043.32 EUR · to 2,481,298.61 EUR · 4,602 new shares
  40. 17-08-2016 Capital increase of 719,224.50 EUR · to 2,004,255.29 EUR
  41. 16-11-2015 Capital increase of 217,549.56 EUR · to 1,285,030.79 EUR · 2,127 new shares
  42. 21-08-2014 Capital increase of 306.84 EUR · to 1,067,481.23 EUR · 3 new shares
  43. 19-06-2014 Capital increase of 197,809.52 EUR · to 1,067,174.39 EUR · 1,934 new shares
  44. 19-06-2014 Capital increase of 480,409.16 EUR · to 869,364.87 EUR · 4,697 new shares
  45. 25-04-2013 Capital reduction of 2,559,558.52 EUR · to 388,955.71 EUR
  46. 05-04-2013 Capital increase of 58,147.50 EUR · to 2,703,519.43 EUR · 75 new shares · in kind
  47. 05-04-2013 Capital increase of 244,994.80 EUR · to 2,948,514.23 EUR · 316 new shares · in cash
  48. 03-12-2012 Capital increase of 10,939.50 EUR · to 72,939.50 EUR · 450 new shares
  49. 03-12-2012 Capital increase of 989,060.50 EUR · to 1,062,000 EUR · from reserves
  50. 03-12-2012 Capital increase of 145,848 EUR · to 1,207,848 EUR · 412 new shares
  51. 03-12-2012 Capital increase of 2,604,152 EUR · to 3,812,000 EUR · from reserves
  52. 03-12-2012 Capital reduction of 1,166,628.07 EUR · to 2,645,371.93 EUR
  53. 10-10-2012 Capital reduction of 1,166,628.07 EUR · to 2,645,371.93 EUR · to absorb losses
  54. 08-06-2012 Capital increase of 2,750,000 EUR · to 3,812,000 EUR · 410 new shares
  55. 01-04-2011 Capital increase of 93,000 EUR · to 155,000 EUR · 450 new shares · in cash
  56. 01-04-2011 Capital increase of 907,000 EUR · to 1,062,000 EUR · no new shares · from reserves
  57. 17-07-2009 Incorporation · 62,000 EUR · 300 shares

Public money · subsidies and aid

European research

1 project · 1 as coordinator · 50,000 EUR EU contribution
Programmes
Horizon 2020
1 entry · 50,000 EUR
Projects
Ultra-small implanted neurostimulation device for the treatment of Obstructive Sleep Apnea
Horizon 2020 · coordinator · 01-06-2016 to 30-09-2016 · 50,000 EUR · Nyxoah

Recognitions · licences · registrations

Legal Entity Identifier

5493002O1ESKZ18OXR80
live in the LEI register

Similar companies · same sector, comparable size

Of 1,249 companies in sector 32500 we hold annual accounts for 694. 25 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded15-07-2009
Fiscal year end31-12
Activities, NACEBEL 2025
32500Manufacture of medical and dental instruments and supplies
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 22 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.

General meetings

3 convocations
Extraordinary general meeting
on 02-07-2025 at 14u · published 13-06-2025
Agenda
sont invités à exercer leurs droits de vote avant l’assemblée en suivant les règles énoncées dans la présente convocation, soit en votant à distance par correspondance, soit en donnant une procuration à un représentant de la Société. Afin de faciliter la tenue de la liste de présence le jour de l’assemblée générale extraordinaire, les détenteurs de titres émis par la Société et leurs représentants sont invités à s’inscrire à partir de 13 h 45 m CET. ORDRE DU JOUR DE L’ASSEMBLEE GENERALE EXTRAORDINAIRE DES ACTIONNAIRES : 1. Ajout de paragraphes à la fin de l’article 13 des statuts de la Société afin d’introduire le droit de désigner des administrateurs
General meeting
on 19-12-2024 at 15u · published 19-11-2024
Agenda
sont invités à exercer leurs droits de vote avant l’assemblée générale spéciale en suivant les règles énoncées dans la présente convocation, soit en votant à distance par courrier, soit en donnant une procuration à un représentant de la Société. Afin de faciliter la tenue de la liste de présence le jour de l’assemblée générale spéciale, les détenteurs de titres émis par la Société et leurs représentants sont invités à s’inscrire à partir de 14 h 45 m CET. ORDRE DU JOUR DE L’ASSEMBLEE GENERALE SPECIALE : 1. Approbation de toutes les clauses pertinentes des Conventions de la BEI conformément à l’article 7 :151 du Code belge des sociétés et des associations. Comme annoncé le 3 juillet 2024, la ...
Extraordinary general meeting
on 12-06-2024 at 14u · published 10-05-2024
DE L’ASSEMBLEE GENERALE ANNUELLE DES ACTIONNAIRES : 1. Prise de connaissance du/des et discussion sur : a. Les comptes annuels